logo
Indignant Melania Trump boldly addresses breast implant rumors in resurfaced interview

Indignant Melania Trump boldly addresses breast implant rumors in resurfaced interview

Daily Mail​5 days ago
Melania Trump didn't hold back when asked about long-standing rumors she'd had breast implants, quickly shutting down the speculation in a now-resurfaced interview.
Speaking to GQ in 2016, the former model discussed her family, her relationship with President Donald Trump, and what her life looks like behind the scenes.
During the chat, the First Lady, 55, also firmly denied going under the knife, insisting at the time that her figure was entirely natural.
'I didn't make any changes,' she told GQ with a scoff when asked directly if she had a boob job.
At the time, she said she was against 'damaging' injections like Botox and credited her youthful appearance with simply taking good care of herself.
'A lot of people say I am using all the procedures for my face. I didn't do anything,' she continued.
'I live a healthy life, I take care of my skin and my body. I'm against Botox, I'm against injections; I think it's damaging your face, damaging your nerves.
'It's all me. I will age gracefully, as my mom does.'
Despite Melania's denial of any work, plastic surgeon to the stars Dr. Gary Motykie theorized last year that she had spent $50,000 on 'maintenance work.'
The surgeon told The Daily Mail: 'I don't see too much reason to be suspicious for a face lift... and I don't think she's had a brow lift either.
'[But] I have noticed a change in her nose. Noses don't typically get smaller as they get older; they get bigger - but hers is definitely smaller and more defined, so I am very suspicious for at least one rhinoplasty [nose job].
'I do think she's likely doing the maintenance work as well - fillers, particularly in the mid-face, cheeks, maybe a touch in the lips, and the standard Botox upkeep.'
Another plastic surgeon, Dr Gary Linkov, argued the First Lady has had extensive cosmetic work, including a nose job, fillers, Botox, cheek implants, and even a facelift.
Aside from speculated surgeries, Melania also keeps up her eye-catching physique with a healthy diet and strict exercise regimen.
Both Pilates and tennis are a core part of Melania's fitness routine, as the activities are easy to do at home or at Mar-a-Lago.
However, the Slovenian stunner previously revealed that she actually owes much of her slender physique to a small tweak she's made to her daily routine.
In the same 2016 interview with GQ, the former supermodel said she wears ankle weights most days, which are said to increase calorie burn anywhere from five to 15 percent.
But it's really Melania's diet that is the biggest contributor to her trim figure.
The Vogue cover girl eats seven pieces of fresh fruit each day, with peaches and apples being her two favorites, according to Inside Edition.
Melania also starts her day with a healthy fruit and vegetable smoothie made of ingredients like spinach, carrots, blueberries, apples, and fat-free yogurt.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump accused of 'selling out' to Big Tech with bold plan for a 'new private health tracking system' sparking data leak worries
Trump accused of 'selling out' to Big Tech with bold plan for a 'new private health tracking system' sparking data leak worries

Daily Mail​

time21 minutes ago

  • Daily Mail​

Trump accused of 'selling out' to Big Tech with bold plan for a 'new private health tracking system' sparking data leak worries

President Donald Trump is being criticized for a plan that would have Americans share their personal health data with private tech companies. In the East Room on Wednesday, Trump hosted a 'Making Health Technology Great Again' event that unveiled the proposal. The Centers of Medicare & Medicaid Services is securing commitments from top tech companies including Amazon, Apple, Google and OpenAI to start building a 'digital health ecosystem.' The goal would be that Americans could upload their health records to an app that could be easily shared across doctors' offices. 'For decades America's healthcare networks have been overdue for a high tech upgrade - and that's what we're doing,' the president told the crowd. 'The existing systems are often slow, costly and incompatible with one another. But with today's announcement, we take a major step to bring healthcare into the digital age.' Trump said this public-private partnership would move the country away from 'clipboards and fax machines into a new era of convenience, profitability and speed and, frankly, better health for people.' Online, Americans were skeptical of the plan, voicing concern that the president was selling out to 'big tech.' 'More corruption and selling America out to big tech,' one X user posted. Others feared a massive data breach. 'I can see the headlines now, Millions of users have personal health data leaked,' another said. Lawrence Gostin, a Georgetown University law professor who specializes in public health told the Associated Press, 'There are enormous ethical and legal concerns.' 'Patients across America should be very worried that their medical records are going to be used in ways that harm them and their families,' Gostin said. Officials at CMS argued that users would have to opt-in to use these services. Helping sell the plan is Amy Gleason, an adviser to CMS and the Department of Health and Human Services, who's the acting administrator of the Department of Government Efficiency. Gleason made headlines in March when it was revealed that she, not Elon Musk, was technically in charge of the Trump administration's DOGE efforts. She starred in a CMS promotional video about the effort - and appeared on a panel alongside Trump, CMS Administrator Dr. Mehmet Oz and HHS Secretary Robert F. Kennedy Jr. Wednesday afternoon. Gleason spoke about her daughter Morgan who suffers from a rare disease. She recalled how she carried a 'binder of paper records' to every doctor's appointment. 'And I truly believe that if one of those doctors had been able to see her whole history, they would have diagnosed her faster,' Gleason said. She added that if her daughter had access to today's AI tools, a diagnosis may have come quicker as well. 'Today Morgan takes 21 pills a day, gets two infusions a month and has over 40 patient portals,' Gleason said. 'Her disease is very rare, but her experience is very common.' Gleason then asked the audience to envision what healthcare could look like with this big tech-government partnership. 'So Morgan, in six months from now, might show up to her doctor's appointment,' she said. 'Instead of filling out a clipboard with her 21 medications, 12 doctors and her entire medical history, she can just pull out her phone and tap or scan a QR code and seamlessly transfer her digital insurance card, her verified medical record and a digital summary that can help her provider get up to speed faster.' 'We call this "kill the clipboard" as President Trump said,' Gleason said.

AbbVie in talks to acquire Gilgamesh Pharmaceuticals, Bloomberg News reports
AbbVie in talks to acquire Gilgamesh Pharmaceuticals, Bloomberg News reports

Reuters

timean hour ago

  • Reuters

AbbVie in talks to acquire Gilgamesh Pharmaceuticals, Bloomberg News reports

July 30 (Reuters) - Drugmaker AbbVie (ABBV.N), opens new tab is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about $1 billion, Bloomberg News reported on Wednesday, citing people familiar with the matter. The U.S. drugmaker has spent over $20 billion on acquisitions since 2023 as its flagship rheumatoid arthritis treatment, Humira, lost patent protection. Gilgamesh is a clinical-stage company developing therapies for psychiatric disorders, including depression, anxiety and post-traumatic stress disorder. In May, AbbVie said it is partnering with Gilgamesh to develop therapies for psychiatric disorders, under which Gilgamesh could receive up to $1.95 billion in option fees and milestone payments. Deliberations over the acquisition are ongoing and could be delayed or fall apart, Bloomberg News reported. AbbVie and Gilgamesh did not immediately respond to Reuters' requests for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store